Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

TTonix Pharmaceuticals Holding Corp.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
T

Tonix Pharmaceuticals Holding Corp.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions

News

News

  • Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®
    Sep 22, 2026Tonix Pharmaceuticals Holding Corp. (TNXP) Press Releases
  • Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
    Sep 8, 2026Tonix Pharmaceuticals Holding Corp. (TNXP) Press Releases
  • September 2026 Investor Deck
    Sep 3, 2026Tonix Pharmaceuticals Holding Corp. (TNXP) Presentations
  • September 2026 Investor Deck
    Sep 3, 2026Tonix Pharmaceuticals Holding Corp. (TNXP) Presentations
  • Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference
    Sep 2, 2026Tonix Pharmaceuticals Holding Corp. (TNXP) Press Releases
  • Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights
    Aug 10, 2026Tonix Pharmaceuticals Holding Corp. (TNXP) Press Releases
  • Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences
    Aug 5, 2026Tonix Pharmaceuticals Holding Corp. (TNXP) Press Releases
  • Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S.
    Aug 3, 2026Tonix Pharmaceuticals Holding Corp. (TNXP) Press Releases
  • TNX-4800 for Lyme Disease Prevention in the U.S.
    Aug 3, 2026Tonix Pharmaceuticals Holding Corp. (TNXP) Presentations
  • TNX-4800 for Lyme Disease Prevention in the U.S.
    Aug 3, 2026Tonix Pharmaceuticals Holding Corp. (TNXP) Presentations
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • News
  • Insider Transactions
$10.59Close · Sep 22, 2026